US 12,303,510 B2
Inhibitory effect of low molecular weight compound on cancer and fibrosis
Goshi Shiota, Yonago (JP); Noriko Itaba, Yonago (JP); Keita Kanki, Yonago (JP); Kenzo Seto, Yonago (JP); Hiroki Shimizu, Yonago (JP); Yohei Kouno, Yonago (JP); Shinya Kunita, Yonago (JP); Zyunya Adumi, Yonago (JP); Tomohiko Sakabe, Yonago (JP); Kenichiro Abe, Yonago (JP); Minoru Morimoto, Tottori (JP); and Hiroyuki Oka, Tottori (JP)
Assigned to National University Corporation Tottori University, Tottori (JP); and KanonCure, Inc., Yonago (JP)
Filed by National University Corporation Tottori University, Tottori (JP); and KanonCure, Inc., Yonago (JP)
Filed on Aug. 27, 2021, as Appl. No. 17/459,117.
Application 17/459,117 is a division of application No. 15/128,608, granted, now 11,213,527, previously published as PCT/JP2015/059257, filed on Mar. 25, 2015.
Claims priority of application No. 2014-070245 (JP), filed on Mar. 28, 2014.
Prior Publication US 2021/0386747 A1, Dec. 16, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/519 (2006.01); A61K 31/09 (2006.01); A61K 31/16 (2006.01); A61K 31/166 (2006.01)
CPC A61K 31/519 (2013.01) [A61K 31/09 (2013.01); A61K 31/16 (2013.01); A61K 31/166 (2013.01)] 6 Claims
 
1. A method of treating a malignant liver tumor, comprising the step of administering to a subject a compound of formula (3), a salt thereof, or a solvate thereof:

OG Complex Work Unit Chemistry